In the News

Updates from our corporate transactions and portfolio companies

Transaction
|
August 11, 2022

MolecuLight Secures Financing from BDC Canada and iGan Partners to Support its Commercial Expansion

MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads, announced that it has completed a financing with BDC Capital and iGan Ventures. The funds are to support MolecuLight's continued global expansion to meet growing customer demand for its MolecuLight i:X® and DX™ devices.

READ MORE
Transaction
|
March 11, 2022

Synthetic Biologics Completes Acquisition of VCN Biosciences

Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need, today announced that it has completed the acquisition of VCN Biosciences, S.L. (VCN) following the satisfaction of all closing conditions.

READ MORE
Transaction
|
January 4, 2022

SWK Holdings Provides $10M USD to MolecuLight to Support Global Commercial Expansion

MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads, announces that SWK Holdings Corporation has provided $10M USD structured debt to support MolecuLight's global commercial expansion. SWK Holdings Corporation (Nasdaq: SWKH) is a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies through the creation of unique financing structures.

READ MORE
Transaction
|
December 18, 2021

SYN Acquires Novel Oncology Biotech VCN Biosciences

Following the VCN acquisition the company still has about $65M in cash and a rich and growing pipeline. SYN investors could enjoy potential 500% gains In 1H 2022.

READ MORE
Transaction
|
December 14, 2021

Synthetic Biologics to acquire VCN Biosciences for over $4M in upfront cash

Synthetic Biologics (NYSE:SYN) has added ~2.9% in the pre-market after announcing a definitive agreement to acquire VCN Biosciences, a privately owned clinical-stage immuno-oncology company based in Spain.

READ MORE
Transaction
|
December 14, 2021

Synthetic Biologics Announces Planned Transformative Acquisition of VCN Biosciences; Developer of a Novel Oncolytic Virus Platform Targeting Pancreatic and other Solid Tumors

Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need, today announced it has signed a definitive agreement to acquire VCN Biosciences, S.L. (VCN), which is developing a new oncolytic adenovirus (OV) platform designed for intravenous (IV) delivery to trigger tumor cell death and promote immune cell infiltration into tumors.

READ MORE
Transaction
|
November 11, 2021

Municipal Finance & Services Corp. Receives Growth Funding Commitment of Up to $5m From Sixth Borough Capital Management

Municipal Finance & Services Corp. (MFSC), a company focused on government arbitrage and committed to helping local governments and their vendors streamline and digitize the payments process to expand local government participation opportunities for minority-owned, women-owned, veteran / disabled veteran-owned, and the underserved/emerging business sector announced the completion of an equity commitment of up to $5M from Sixth Borough Capital Management.

READ MORE
Portfolio
|
June 20, 2020

Healthy.io acquires fellow smartphone urinalysis startup Inui Health

Israel-based smartphone urinalysis and wound-care startup Healthy.io is purchasing fellow home-diagnostics company Inui Health in a roughly $9 million cash deal, CNBC reports. The agreement also involves milestones that Inui Health will need to meet, and sees CEO Dr. Jaime Tenedorio take on a new role within Healthy.io's team.

READ MORE
Portfolio
|
October 21, 2019

Medinas Raises $5M Seed For Its Healthcare Equipment Marketplace

For Chloe Alpert, one of the biggest surprises of starting her own company begins with a CT scanner and ends with a boat ride. Subscribe to the Crunchbase Daily Alpert is the CEO and co-founder of Medinas, a software-fueled marketplace for reusable medical equipment. The company resells equipment from medical centers to other places, and handles all aspects of the sale from the beginning inventory check to shipment and reinstallation.

READ MORE
Portfolio
|
January 10, 2019

Medinas Health CEO Wins $1 Million at WeWork Creator Awards

Chloé Alpert, the CEO of Bay Area-based start-up Medinas Health, joins Cheddar fresh off winning $1 million at the WeWork Creator Awards Global Finals. She discusses how the new influx of capital will help her company continue to disrupt the healthcare industry, and what she learned from judges Ashton Kutcher, Diddy, and Gary Vaynerchuk.

READ MORE
Portfolio
|
August 22, 2018

The top 10 startups from Y Combinator’s Demo Day S18 Day 2

Fifty-nine startups took the stage at Y Combinator’s Demo Day 2, and among the highlights were a company that helps developers manage in-app subscriptions; a service that lets you create animojis from real photos; and a surplus medical equipment-reselling platform.

READ MORE
Portfolio
|
March 16, 2018

Medinas Health Closes $1M Seed Funding Round

Medinas Health, a San Francisco, CA-based marketplace for healthcare organizations to buy and sell surplus and short-date medical supplies and equipment, raised $1M in seed funding.

READ MORE
Portfolio
|
November 14, 2017

How Medical Supply Startup Medinas Uses Serverless to Tackle a $765 Billion Problem

If you were to walk into any surplus medical supply donation center in the U.S., you would immediately notice how much stuff lines the walls. Perfectly usable items like adhesive dressings, bandages, syringes, and surgical masks sit waiting to be donated to remote healthcare clinics and hospitals around the world simply because they will expire in a matter of months—and in some cases, even years.

READ MORE
Portfolio
|
October 2, 2017

Medinas Wins $500,000 Forbes Under 30 Summit's Global Change The World For-Profit Competition

Forbes, Sound Ventures and Rough Draft Ventures (powered by General Catalyst) today announced that Medinas won the Forbes Global Change the World competition for young for-profit entrepreneurs as part of the 2017 Forbes Under 30 Summit, taking place October 1-4 in Boston.

READ MORE
Portfolio
|
June 29, 2017

LipoSeuticals Inc Announces The Completion Of Series A Financing

LipoSeuticals, Inc. (LSI), a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of parenteral drug products based on its proprietary and novel drug delivery technology, announced today that it recently closed a financing round for an undisclosed amount led by Delos Capital, a Hong Kong based life sciences fund.

READ MORE
Have a lightbulb moment with us
Sign up for updates from Tungsten
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.